Aβ immunogenic peptide carrier conjugates and methods of producing same
First Claim
1. A method of producing an immunogenic conjugate, the method comprising the steps of:
- (a) adding a carboxy-terminal cysteine residue to an Aβ
fragment comprising residues 1-7 of Aβ
(SEQ ID NO;
21);
(b) derivatizing one or more lysine residues of a CRM197 carrier protein to generate an activated functional group on the carrier protein;
(c) reacting the peptide immunogen comprising residues 1-7 of Aβ
(SEQ ID NO;
21) and the carboxy-terminal cysteine residue with the carrier protein of step (b) under conditions to form a conjugate; and
(d) further reacting the conjugate of step (c) with N-acetylcysteamine to inactivate any remaining activated functional group on the carrier protein to generate the immunogenic conjugate,wherein the immunogenic conjugate has the formula;
8 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to methods of producing conjugates of Aβ peptide immunogens with protein/polypeptide carrier molecules, which are useful as immunogens, wherein peptide immunogens are conjugated to protein carriers via activated functional groups on amino acid residues of the carrier or of the optionally attached linker molecule, and wherein any unconjugated reactive functional groups on amino acid residues are inactivated via capping, thus retaining the immunological functionality of the carrier molecule, but reducing the propensity for undesirable reactions that could render the conjugate less safe or effective. Furthermore, the invention also relates to such immunogenic products and immunogenic compositions containing such immunogenic products made by such methods.
77 Citations
10 Claims
-
1. A method of producing an immunogenic conjugate, the method comprising the steps of:
-
(a) adding a carboxy-terminal cysteine residue to an Aβ
fragment comprising residues 1-7 of Aβ
(SEQ ID NO;
21);(b) derivatizing one or more lysine residues of a CRM197 carrier protein to generate an activated functional group on the carrier protein; (c) reacting the peptide immunogen comprising residues 1-7 of Aβ
(SEQ ID NO;
21) and the carboxy-terminal cysteine residue with the carrier protein of step (b) under conditions to form a conjugate; and(d) further reacting the conjugate of step (c) with N-acetylcysteamine to inactivate any remaining activated functional group on the carrier protein to generate the immunogenic conjugate, wherein the immunogenic conjugate has the formula; - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
Specification